플루르비프로펜

동물 종별 용량

용량은 면허 수의 전문가를 위한 임상 참고 자료입니다. 항상 최신 라벨과 개별 환자에 대해 확인하십시오.

투여 경로

금기

• Hypersensitivity to flurbiprofen or other NSAIDs
• Active corneal ulceration (relative contraindication)
• Bleeding disorders
• Hypersensitivity to NSAIDs
• Active intraocular bleeding
• Corneal ulceration (use with extreme caution)
• Epithelial herpes simplex keratitis

이상반응

• Transient ocular stinging or burning upon application
• Delayed corneal healing
• Increased risk of ocular bleeding during surgery
• Corneal melting (rare but severe)
• Transient stinging or burning upon instillation
• Ocular irritation
• Increased bleeding tendency of ocular tissues (rare)

약물 상호작용

• Topical Corticosteroids · Concurrent use may increase the risk of delayed corneal healing and severe complications such as corneal melting. · moderate
• Topical Prostaglandin Analogues (e.g., Latanoprost) · NSAIDs may blunt the intraocular pressure-lowering efficacy of topical prostaglandins. · minor
• Topical prostaglandins (e.g., Latanoprost) · NSAIDs may decrease the intraocular pressure-lowering efficacy of topical prostaglandin analogues. · minor

모니터링

• Resolution of ocular inflammation (flare and cells in the anterior chamber)
• Intraocular pressure (IOP)
• Corneal integrity (via fluorescein staining)
• Resolution of ocular inflammation
• Maintenance of pupillary dilation during surgery
• Corneal integrity (via fluorescein staining) if used long-term

과용량

Topical overdose is unlikely to cause systemic toxicity due to the small volume administered. Ocular overdosage may lead to increased local irritation, hyperemia, and delayed corneal healing. If significant overexposure occurs, flush the eye with sterile saline.